2m 2m 2m 2m 2m 2m 2m
REGENCELL (RGC)
NASDAQ
$5.26+$0.21 (+4.08%)
Price as of Jul 14, 2026 4:40 AM EDT- N/AMarket Cap
- -65.60%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
REGENCELL (RGC)
$5.26+$0.21 (+4.08%)
RGC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.05 | ||
Change | -$0.83 (-14.12%) | ||
Open | $5.99 | ||
High | $5.99 | ||
Low | $4.92 | ||
Previous Close | $5.88 | ||
Volume | 476,169 | ||
30-Day Average Volume | 595,503 | ||
1-Week Change | -9.98% | ||
1-Month Change | -73.18% | ||
1-Year Change | -65.60% | ||
3-Year Change | 779.07% | ||
5-Year Change | 734.71% | ||
Fundamentals | |||
Shares Outstanding | 494.5M | ||
Total Assets | $5.8M | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 02/15/2018 | ||
Last Split Factor | 38 : 1 | ||
Last Split Date | 06/16/2025 | ||